P1164: PEGARSPARGASE AND SINTILIMAB FOR NEWLY DIAGNOSED, ADVANCED STAGE NATURAL KILLER T-CELL LYMPHOMA, NASAL TYPE: AN OPEN-LABEL, SINGLE-ARM, PHASE 2 STUDY.

Detalles Bibliográficos
Autores principales: Xiong, Jie, Cheng, Shu, Wang, LI, Xu, Peng-Peng, Zhao, Wei-LI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431121/
http://dx.doi.org/10.1097/01.HS9.0000971552.07464.0b
_version_ 1785091124905377792
author Xiong, Jie
Cheng, Shu
Wang, LI
Xu, Peng-Peng
Zhao, Wei-LI
author_facet Xiong, Jie
Cheng, Shu
Wang, LI
Xu, Peng-Peng
Zhao, Wei-LI
author_sort Xiong, Jie
collection PubMed
description
format Online
Article
Text
id pubmed-10431121
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311212023-08-17 P1164: PEGARSPARGASE AND SINTILIMAB FOR NEWLY DIAGNOSED, ADVANCED STAGE NATURAL KILLER T-CELL LYMPHOMA, NASAL TYPE: AN OPEN-LABEL, SINGLE-ARM, PHASE 2 STUDY. Xiong, Jie Cheng, Shu Wang, LI Xu, Peng-Peng Zhao, Wei-LI Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431121/ http://dx.doi.org/10.1097/01.HS9.0000971552.07464.0b Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Xiong, Jie
Cheng, Shu
Wang, LI
Xu, Peng-Peng
Zhao, Wei-LI
P1164: PEGARSPARGASE AND SINTILIMAB FOR NEWLY DIAGNOSED, ADVANCED STAGE NATURAL KILLER T-CELL LYMPHOMA, NASAL TYPE: AN OPEN-LABEL, SINGLE-ARM, PHASE 2 STUDY.
title P1164: PEGARSPARGASE AND SINTILIMAB FOR NEWLY DIAGNOSED, ADVANCED STAGE NATURAL KILLER T-CELL LYMPHOMA, NASAL TYPE: AN OPEN-LABEL, SINGLE-ARM, PHASE 2 STUDY.
title_full P1164: PEGARSPARGASE AND SINTILIMAB FOR NEWLY DIAGNOSED, ADVANCED STAGE NATURAL KILLER T-CELL LYMPHOMA, NASAL TYPE: AN OPEN-LABEL, SINGLE-ARM, PHASE 2 STUDY.
title_fullStr P1164: PEGARSPARGASE AND SINTILIMAB FOR NEWLY DIAGNOSED, ADVANCED STAGE NATURAL KILLER T-CELL LYMPHOMA, NASAL TYPE: AN OPEN-LABEL, SINGLE-ARM, PHASE 2 STUDY.
title_full_unstemmed P1164: PEGARSPARGASE AND SINTILIMAB FOR NEWLY DIAGNOSED, ADVANCED STAGE NATURAL KILLER T-CELL LYMPHOMA, NASAL TYPE: AN OPEN-LABEL, SINGLE-ARM, PHASE 2 STUDY.
title_short P1164: PEGARSPARGASE AND SINTILIMAB FOR NEWLY DIAGNOSED, ADVANCED STAGE NATURAL KILLER T-CELL LYMPHOMA, NASAL TYPE: AN OPEN-LABEL, SINGLE-ARM, PHASE 2 STUDY.
title_sort p1164: pegarspargase and sintilimab for newly diagnosed, advanced stage natural killer t-cell lymphoma, nasal type: an open-label, single-arm, phase 2 study.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431121/
http://dx.doi.org/10.1097/01.HS9.0000971552.07464.0b
work_keys_str_mv AT xiongjie p1164pegarspargaseandsintilimabfornewlydiagnosedadvancedstagenaturalkillertcelllymphomanasaltypeanopenlabelsinglearmphase2study
AT chengshu p1164pegarspargaseandsintilimabfornewlydiagnosedadvancedstagenaturalkillertcelllymphomanasaltypeanopenlabelsinglearmphase2study
AT wangli p1164pegarspargaseandsintilimabfornewlydiagnosedadvancedstagenaturalkillertcelllymphomanasaltypeanopenlabelsinglearmphase2study
AT xupengpeng p1164pegarspargaseandsintilimabfornewlydiagnosedadvancedstagenaturalkillertcelllymphomanasaltypeanopenlabelsinglearmphase2study
AT zhaoweili p1164pegarspargaseandsintilimabfornewlydiagnosedadvancedstagenaturalkillertcelllymphomanasaltypeanopenlabelsinglearmphase2study

Ejemplares similares